| Type | Investment In | Percentage of NAV | No. of shares | Value(Rs in cr) |
| Domestic Equities | Sun Pharmaceutical Industries Ltd. | 11.0898 | 52436 | 9.1081 |
| Domestic Equities | Torrent Pharmaceuticals Ltd. | 6.9275 | 13130 | 5.6896 |
| Domestic Equities | Apollo Hospitals Enterprise Ltd. | 6.8730 | 7217 | 5.6448 |
| Domestic Equities | Fortis Healthcare Ltd. | 4.9390 | 43032 | 4.0564 |
| Domestic Equities | Divi's Laboratories Ltd. | 4.8051 | 6158 | 3.9464 |
| Domestic Equities | Aurobindo Pharma Ltd. | 4.6512 | 31301 | 3.8200 |
| Domestic Equities | Piramal Pharma Ltd. | 4.2979 | 226088 | 3.5299 |
| Domestic Equities | Neuland Laboratories Ltd. | 4.0366 | 2585 | 3.3153 |
| Domestic Equities | Onesource Specialty Pharma Ltd. | 3.6337 | 22159 | 2.9844 |
| Domestic Equities | Alkem Laboratories Ltd. | 3.4388 | 5008 | 2.8243 |
| Domestic Equities | Cipla Ltd. | 3.2120 | 19567 | 2.6380 |
| Domestic Equities | Navin Fluorine International Ltd. | 3.1355 | 4116 | 2.5752 |
| Domestic Equities | Abbott India Ltd. | 3.1269 | 968 | 2.5681 |
| Domestic Equities | Glenmark Pharmaceuticals Ltd. | 3.1204 | 11994 | 2.5628 |
| Domestic Equities | Gland Pharma Ltd. | 3.1157 | 14043 | 2.5589 |
| Domestic Equities | IPCA Laboratories Ltd. | 3.0909 | 16604 | 2.5386 |
| Domestic Equities | Concord Biotech Ltd. | 3.0513 | 20531 | 2.5060 |
| Domestic Equities | Metropolis Healthcare Ltd. | 2.7413 | 11826 | 2.2514 |
| Domestic Equities | Artemis Medicare Services Ltd. | 2.7320 | 93529 | 2.2438 |
| Domestic Equities | Mankind Pharma Ltd. | 2.3473 | 8577 | 1.9278 |
| Domestic Equities | Max Healthcare Institute Ltd. | 2.2302 | 16775 | 1.8317 |
| Domestic Equities | Dr Agarwal's Health Care Ltd. | 2.1765 | 39576 | 1.7876 |
| Domestic Equities | Anthem Biosciences Ltd. | 2.1630 | 25333 | 1.7765 |
| Domestic Equities | Global Health Ltd. | 2.0732 | 14952 | 1.7027 |
| Domestic Equities | Acutaas Chemicals Ltd. | 1.6549 | 6296 | 1.3592 |
| Domestic Equities | Vinati Organics Ltd. | 1.5668 | 8741 | 1.2868 |
| Total | | 96.2306 | | 79.0343 |
| Cash & Cash Equivalents and Net Assets | Treps | 3.9022 | | 3.2049 |
| Cash & Cash Equivalents and Net Assets | Net Receivables / (Payables) | -0.1328 | | -0.1091 |
| Total | | 3.7694 | | 3.0958 |